Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran,

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03698084` - RESCEU: Defining the Burden of RSV Disease
Recruiting	`NCT05550545` - Infant RSV Infections and Health-related Quality of Life of Families
Completed	`NCT05587478` - A Study of EDP-323 in Healthy Subjects	Phase 1
Recruiting	`NCT06180993` - Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Suspended	`NCT03909867` - Emission Patterns of Respiratory Syncytial Virus
Recruiting	`NCT06259487` - Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.	N/A
Not yet recruiting	`NCT04144816` - Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in Infants
Completed	`NCT01090557` - Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study	N/A
Terminated	`NCT01475305` - Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)	Phase 1
Not yet recruiting	`NCT05928507` - FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol
Completed	`NCT03062917` - Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis	N/A
Completed	`NCT03691623` - A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model	Phase 2
Completed	`NCT03387137` - Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children	Phase 1
Completed	`NCT05070975` - Severity of RSV Infections in Twins
Active, not recruiting	`NCT04938830` - Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)	Phase 3
Recruiting	`NCT05568706` - A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.	Phase 2
Completed	`NCT03755778` - Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects	Phase 1
Completed	`NCT01483911` - ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers	Phase 1
Recruiting	`NCT06170242` - A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model	Phase 2
Completed	`NCT03750383` - Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects	Phase 1

NCT number	NCT04498741
Study type	Interventional
Source	Enanta Pharmaceuticals
Contact
Status	Completed
Phase	Phase 1
Start date	July 8, 2020
Completion date	June 1, 2021

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms